Stocksigma LogoStocksigma Logo

Eris Lifesciences Schedules Board Meeting for Q2 FY27 Financial Results

Eris Lifesciences Limited has scheduled a Board of Directors meeting on 26th Oct'26 to consider and approve its standalone and consolidated unaudited

Eris Lifesciences Schedules Board Meeting for Q2 FY27 Financial Results

Eris Lifesciences Ltd 路 Intimation 路 26 Oct 2026, 5:30 am

Eris Lifesciences Schedules Board Meeting for Q2 FY27 Financial Results Eris Lifesciences Limited has scheduled a Board of Directors meeting on 26th Oct'26 to consider and approve its standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI Insider Trading Regulations, the company's trading window for designated persons has been closed since 1st Oct'26 and will remain shut until 48 hours post the official declaration of the financial results.

Original exchange filing (PDF)

More announcements from Eris Lifesciences Ltd

All Eris Lifesciences Ltd announcements